Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Roger Logan"'
Autor:
Sara Lodi, Marina Klein, Andri Rauch, Rachel Epstein, Linda Wittkop, Roger Logan, Christopher T. Rentsch, Amy C. Justice, Giota Touloumi, Juan Berenguer, Inma Jarrin, Matthias Egger, Massimo Puoti, Antonella D'Arminio Monforte, John Gill, Dominique Salmon Ceron, Ard vanSighem, Benjamin Linas, Marc van derValk, Miguel A. Hernán, HepCAUSAL Collaboration
Publikováno v:
Journal of the International AIDS Society, Vol 25, Iss 12, Pp n/a-n/a (2022)
Abstract Introduction Randomized trials and observational studies have consistently reported rates of sustained virological response (SVR), equivalent to hepatitis C virus (HCV) cure, as high as 95% following treatment with direct‐acting antiviral
Externí odkaz:
https://doaj.org/article/f124f0190b1f48b882f1fdd59c20249d
Autor:
Saima Hilal, Sonja A. Swanson, Mohammad Arfan Ikram, Roger Logan, Eleanor J Murray, Liliana Paloma Rojas-Saunero
Publikováno v:
European Journal of Epidemiology
European Journal of Epidemiology, 36(1), 69-79. Springer Netherlands
European Journal of Epidemiology, 36(1), 69-79. Springer Netherlands
We aimed to study the effects of hypothetical interventions on systolic blood pressure (SBP) and smoking on risk of stroke and dementia using data from 15 years of follow-up in the Rotterdam Study. We used data from 4930 individuals, aged 55–80 yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437eb3591d8276845835d4263db87fe0
https://doi.org/10.1007/s10654-020-00694-5
https://doi.org/10.1007/s10654-020-00694-5
Publikováno v:
Int J Epidemiol
Background Previous case-control studies have reported a strong association between statin use and lower cancer risk. It is unclear whether this association reflects a benefit of statins or is the result of design decisions that cannot be mapped to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7dba4e8fa8695cf395f0ae821133433
https://doi.org/10.1093/ije/dyaa144
https://doi.org/10.1093/ije/dyaa144
Autor:
Roger Logan, Jessica Chubak, Bruce M. Psaty, Kerri L. Wiggins, Miguel A. Hernán, Bahareh Rasouli, Rod L. Walker, Goodarz Danaei, Matthew Nguyen, Barbra A. Dickerman, James S. Floyd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb2ec5a8b6240a7a5605ceacac83edb6
https://doi.org/10.25302/07.2021.me.160936748
https://doi.org/10.25302/07.2021.me.160936748
Autor:
Richard Gilson, Inmaculada Jarrín, Sara Lodi, Dimitrios Paraskevis, John Gill, T. Sonia Boender, Huldrych F. Günthard, Heiner C. Bucher, Metallidis Simeon, David Dunn, Georgia Vourli, Reed A C Siemieniuk, Ard van Sighem, Kholoud Porter, Caroline A. Sabin, Sophie Jose, Andrew N. Phillips, Federico García, Santiago Moreno, Miguel A. Hernán, Peter Reiss, Roger Logan, Alexandra U. Scherrer, Quang Vu
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), 82(3), 314-320. Lippincott Williams and Wilkins
J Acquir Immune Defic Syndr
J Acquir Immune Defic Syndr
BACKGROUND: For people living with HIV, major guidelines in high-income countries recommend testing for transmitted drug resistance (TDR) to guide the choice of first-line antiretroviral therapy (ART). However, individuals who fail a first-line regim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbe882d42475dd7552c7166e96cf6b35
https://doi.org/10.1097/qai.0000000000002135
https://doi.org/10.1097/qai.0000000000002135
Publikováno v:
Nat Med
The increasing availability of large healthcare databases is fueling an intense debate on whether real-world data should play a role in the assessment of the benefit-risk of medical treatments. In many observational studies, for example, statin users
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f375106e51781671f11f753150bf050
https://doi.org/10.1038/s41591-019-0597-x
https://doi.org/10.1038/s41591-019-0597-x
Autor:
Miguel A. Hernán, Jessica G. Young, Lucia C. Petito, Victoria Lin, Roger Logan, Zilu Zhang, Sean McGrath
Publikováno v:
Patterns, Vol 1, Iss 3, Pp 100008-(2020)
Patterns (N Y)
Patterns (N Y)
Summary: Researchers are often interested in estimating the causal effects of sustained treatment strategies, i.e., of (hypothetical) interventions involving time-varying treatments. When using observational data, estimating those effects requires ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3be3451eed19283c0be4213e47b664ad
http://www.sciencedirect.com/science/article/pii/S2666389920300088
http://www.sciencedirect.com/science/article/pii/S2666389920300088
Autor:
Xabier García-Albéniz, Miguel A. Hernán, Lucia C. Petito, Angela B. Mariotto, Roger Logan, Issa J Dahabreh, Nadia Howlader
Publikováno v:
JAMA Network Open
Importance The Surveillance, Epidemiology, and End Results (SEER)–Medicare linked database may provide insights into the comparative effectiveness of oncological treatments for elderly individuals who are underrepresented in clinical trials. Object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f68b4bd05f9a1eb7860592c6c7da6503
https://pubmed.ncbi.nlm.nih.gov/32250428
https://pubmed.ncbi.nlm.nih.gov/32250428
Autor:
Xabier García-Albéniz, Roger Logan, Mary Price, Katrina Armstrong, Miguel A. Hernán, John Hsu
Publikováno v:
Annals of internal medicine. 172(6)
Randomized trials have shown that initiating breast cancer screening between ages 50 and 69 years and continuing it for 10 years decreases breast cancer mortality. However, no trials have studied whether or when women can safely stop screening mammog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeddbafb10bd1bce87a9b0ef4faa17da
https://pubmed.ncbi.nlm.nih.gov/32755195
https://pubmed.ncbi.nlm.nih.gov/32755195
Autor:
Sonja A. Swanson, Bruno H. Stricker, Silvan Licher, Saima Hilal, Ellen C. Caniglia, L. Paloma Rojas-Saunero, Roger Logan, M. Arfan Ikram
Publikováno v:
Neurology, 95(10), e1322-e1332. Lippincott Williams & Wilkins
Neurology
Neurology
ObjectiveObservational data can be used to attempt to emulate a target trial of statin use and estimate analogues of intention-to-treat and per protocol effects on dementia risk.MethodsUsing data from a prospective cohort study in the Netherlands, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d59ee33498334dc4639163a568f9a768
https://pure.eur.nl/en/publications/5d2d95f2-4476-4916-93d6-1e7e04aa76ca
https://pure.eur.nl/en/publications/5d2d95f2-4476-4916-93d6-1e7e04aa76ca